[1] Jellinger K A. Neuropathoiology of non-motor symptoms in parkinson disease[J]. J Neural Transm, 2015, 122(10):1429-1440. [2] Jellinger K A. The pathomechanisms underlying parkinson's disease[J]. Expert Rev Neurother,2014, 14(2):199-215. [3] Yu S, Chan P. Role of α-synuclein in neurodegeneration:implications for the pathogenesis of Parkinson's disease[J]. Essays Biochem, 2014, 56:125-135. [4] Braak H, deVos R A, Bohl J, et al. Gastricα-synucleinimmunoreactive inclusions in Meissner's and Auerbach'splex-uses in cases staged for Parkinson's disease-related brain pathology[J]. Neurosci Lett, 2006, 396(1):67-72. [5] Abbott R D, Petrovitch H, White L R, et al. Frequency of bowelmovements and the future risk of Parkinson's disease[J]. Neurology, 2001, 57(3):456-462. [6] Claassen D O, Josephs K A, Ahlskog J E, et al. REM sleep behavior disorder preceding otheraspects of synucleinopathies by up to half a century[J].Neurology, 2010, 75(6):494-499. [7] Scheperjans F, Aho V, Pereira P A, et al.Gut microbiota are related to Parkinson's disease and clinical phenotype[J]. Mov Disord, 2015, 30(3):350-358. [8] Stemberger S, Poewe W, Wenning G K, et al. Targeted over expression of humanα-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure[J]. Exp Neurol, 2010, 224(2):459-464. [9] 李昕, 杨巍巍, 李雁,等. 一种检测帕金森病患者血浆促进α-突触核蛋白寡聚体形成能力的方法[J]. 首都医科大学学报,2013, 34(6):830-834. [10] Chen M, Yang W, Li X, et al. Age-and brain region-dependent α-synucleinoligomerization is attributed to alterations in intrinsic enzymes regulating α-synuclein phosphorylation in aging monkey brains[J]. Oncotarget, 2016, 7(8):8466-8480. [11] Cryan J F, Dinan T G. Mind-altering microorganisms:the impact of the gut microbiota on brain and behavior[J]. Nat Rev Neurosci, 2012, 13(10):701-712. [12] Muntané G, Ferrer I, Martinez-Vicente M. α-Synuclein phosphorylation and truncation are normal events in the adult human brain[J]. Neuroscience,2012, 200:106-119. [13] Kalia L V, Kalia S K, McLean P J, et al. α-Synuclein oligomers and clinical implications for Parkinson disease[J]. Ann Neurol, 2013, 73(2):155-169. [14] Lane M A. Nonhuman primate models in biogerontology[J]. Exp Gerontol, 2000, 35(5):533-541. |